NRXP icon

NRX Pharmaceuticals
NRXP

Overview Fund Activity

30 hedge funds and large institutions have $3.04M invested in NRX Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 8 closing their positions.

Holders
30
Holders Change
-7
Holders Change %
-18.92%
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
11
Reduced
7
Closed
8
Calls
$274K
Puts
$53K
Net Calls
+$221K
Net Calls Change
+$51K

Top Buyers

1
JPMorgan Chase & Co
1
JPMorgan Chase & Co
New York
$650K
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.07M
3
TCBWMS
3
Texas Capital Bank Wealth Management Services
Texas
$47K
4
Simplex Trading
4
Simplex Trading
Illinois
$10K
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$237K

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$0
2
SM
2
Sabby Management
Florida
$0
3
Citadel Advisors
3
Citadel Advisors
Florida
$0
4
Group One Trading
4
Group One Trading
Illinois
$84K
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$32K
Name Holding Trade Value Shares
Change 		Shares
Change %
Millennium Management
26
Millennium Management
New York
– -$178K -29,682 Closed
SM
27
Sabby Management
Florida
– -$120K -20,000 Closed
Citadel Advisors
28
Citadel Advisors
Florida
– -$55K -9,167 Closed
Two Sigma Investments
29
Two Sigma Investments
New York
– -$25K -4,145 Closed
UBS Group
30
UBS Group
Switzerland
– -$10K -1,680 Closed
WAP
31
Wealthcare Advisory Partners
Pennsylvania
– -$8K -1,300 Closed
VF
32
Virtu Financial
New York
– -$8K -1,280 Closed
PCM
33
Penserra Capital Management
California
– -$6K -1,016 Closed
1
2